Table 4 Changes in quality of life as evaluated by the SF-36 questionnaire from baseline to week 16 within each group
SF-36 questionnaire (mean ± SD) | BCAA group | Control group | ||||
|---|---|---|---|---|---|---|
Baseline | At 16 weeks | P-value | Baseline | At 16 weeks | P-value | |
Physical function | 61.0 ± 25.3 | 73.8 ± 21.4 | < 0.001 | 65.0 ± 23.8 | 65.2 ± 21.9 | 0.9 |
Role physical | 73.0 ± 27.9 | 88.0 ± 17.9 | 0.006 | 66.0 ± 26.9 | 61.0 ± 30.7 | 0.096 |
Bodily pain | 73.9 ± 20.2 | 82.6 ± 14.1 | 0.02 | 74.4 ± 16.9 | 75.1 ± 15.8 | 0.66 |
General health | 55.8 ± 19.6 | 65.0 ± 16.9 | 0.02 | 52.4 ± 17.4 | 54.0 ± 18.3 | 0.43 |
Physical component score | 44.1 ± 8.0 | 49.1 ± 6.9 | < 0.001 | 44 ± 8 | 43.1 ± 8.2 | 0.08 |
Role emotion | 81.3 ± 23.7 | 90.7 ± 15.3 | 0.09 | 74.7 ± 24.1 | 78.7 ± 23.3 | 0.33 |
Vitality | 68.0 ± 17.7 | 74.6 ± 13.1 | 0.03 | 68.0 ± 16.4 | 69.8 ± 14.5 | 0.29 |
Mental health | 82.1 ± 13.6 | 85.3 ± 10.3 | 0.18 | 81.9 ± 11.4 | 83.8 ± 9.8 | 0.13 |
Social functioning | 75.0 ± 19.4 | 80.0 ± 17.7 | 0.08 | 77.0 ± 15.6 | 80.5 ± 14.9 | 0.07 |
Mental component score | 55.2 ± 6.2 | 56.7 ± 4.5 | 0.2 | 53.7 ± 5.6 | 54.9 ± 5.6 | 0.07 |